Health Care & Life Sciences » Biotechnology | Human Stem Cells Institute PJS

Human Stem Cells Institute PJS

Human Stem Cells Institute PJS
Stock Exchange Moscow Exchange
EPS
RUB0.46
Market Cap
RUB1.09 B
Shares Outstanding
-
Public Float
-

Profile

Address
18/1, Olimpiyskiy Avenue
Moscow MC 129110
Russian Federation
Employees -
Website http://www.hsci.ru
Updated 07/08/2019
Human Stem Cells Institute OJSC engages in the discovery, research, development, and marketing of proprietary products and services in the field of regenerative medicine, medical genetics, bio-insurance, gene therapy, and biopharmaceutics. Its research and development involves gemacell and cryocell; service for personal regeneration of bone and of gum; nucleostim; preventive treatment program for primary immunodeficiency diseases; human artificial chromosome; development of drugs using histone proteins; and development of drugs using a novel technology employing polysialic acid. The company was founded by Isaev Alexandrovich Artur on November 3, 2003 and is headquartered in Moscow, Russia.

Financials

View All

Alexander Viktorovich Prikhodko
Chairman & Deputy General Director
Artur Alexandrovich Isaev
General Director & Director